Real Clinical Practice Data of Monthly Dupilumab Therapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Clinical Efficacy and Predictive Markers for a Favorable Clinical Response

PURPOSE: Dupilumab is recommended to be administered biweekly to treat adult patients with moderate-to-severe atopic dermatitis (AD). Real clinical practice data on the clinical efficacy of monthly dupilumab therapy are limited. We analyzed real clinical practice data on the clinical efficacy of mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Youngsoo, Kim, Myoung-Eun, Nahm, Dong-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419649/
https://www.ncbi.nlm.nih.gov/pubmed/34486258
http://dx.doi.org/10.4168/aair.2021.13.5.733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419649/
https://www.ncbi.nlm.nih.gov/pubmed/34486258
http://dx.doi.org/10.4168/aair.2021.13.5.733

Ejemplares similares